• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatr Infect Dis J . Risk Factors for Multisystem Inflammatory Syndrome in Children: A Case-Control Investigation

tetano

Editor, Senior Moderator
Pediatr Infect Dis J


. 2023 Mar 16.
doi: 10.1097/INF.0000000000003900. Online ahead of print.
Risk Factors for Multisystem Inflammatory Syndrome in Children: A Case-Control Investigation


Laura D Zambrano[SUP] 1 [/SUP], Michael J Wu[SUP] 1 [/SUP], Lora Martin[SUP] 2 [/SUP], Lacy Malloch[SUP] 2 [/SUP], Sabrina Chen[SUP] 3 [/SUP], Margaret M Newhams[SUP] 3 [/SUP], Mary Beth Son[SUP] 4 5 [/SUP], Cameron Sanders[SUP] 2 [/SUP], Kayla Patterson[SUP] 2 [/SUP], Natasha Halasa[SUP] 6 [/SUP], Julie Fitzgerald[SUP] 7 [/SUP], Matthew Leroue[SUP] 8 [/SUP], Mark Hall[SUP] 9 [/SUP], Katherine Irby[SUP] 10 [/SUP], Courtney M Rowan[SUP] 11 [/SUP], Kari Wellnitz[SUP] 12 [/SUP], Leila Sahni[SUP] 13 [/SUP], Laura Loftis[SUP] 13 [/SUP], Tamara T Bradford[SUP] 14 [/SUP], Mary Staat[SUP] 15 [/SUP], Christopher Babbitt[SUP] 16 [/SUP], Christopher L Carroll[SUP] 17 [/SUP], Pia Pannaraj[SUP] 18 [/SUP], Michele Kong[SUP] 19 [/SUP], Jennifer E Schuster[SUP] 20 [/SUP], Janet Chou[SUP] 4 5 [/SUP], Manish M Patel[SUP] 1 [/SUP], Adrienne G Randolph[SUP] 3 5 21 [/SUP], Angela P Campbell[SUP] 1 [/SUP], Charlotte V Hobbs[SUP] 2 [/SUP]; Overcoming COVID-19 investigators



Affiliations

Abstract

Background: In a 2020 pilot case-control study using medical records, we reported that non-Hispanic Black children were more likely to develop multisystem inflammatory syndrome in children (MIS-C) after adjustment for sociodemographic factors and underlying medical conditions. Using structured interviews, we investigated patient, household, and community factors underlying MIS-C likelihood.
Methods: MIS-C case patients hospitalized in 2021 across 14 US pediatric hospitals were matched by age and site to outpatient controls testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within 3 months of the admission date. Caregiver interviews queried race/ethnicity, medical history, and household and potential community exposures 1 month before MIS-C hospitalization (case-patients) or after SARS-CoV-2 infection (controls). We calculated adjusted odds ratios (aOR) using mixed-effects multivariable logistic regression.
Results: Among 275 case patients and 496 controls, race/ethnicity, social vulnerability and patient or family history of autoimmune/rheumatologic disease were not associated with MIS-C. In previously healthy children, MIS-C was associated with a history of hospitalization for an infection [aOR: 4.8; 95% confidence interval (CI): 2.1-11.0]. Household crowding (aOR: 1.7; 95% CI: 1.2-2.6), large event attendance (aOR: 1.7; 95% CI: 1.3-2.1), school attendance with limited masking (aOR: 2.6; 95% CI: 1.1-6.6), public transit use (aOR: 1.8; 95% CI: 1.4-2.4) and co-resident testing positive for SARS-CoV-2 (aOR: 2.2; 95% CI: 1.3-3.7) were associated with increased MIS-C likelihood, with risk increasing with the number of these factors.
Conclusions: From caregiver interviews, we clarify household and community exposures associated with MIS-C; however, we did not confirm prior associations between sociodemographic factors and MIS-C.
 
Back
Top Bottom